top of page

Vancouver Infectious Diseases Centre

COVID-19 & Sports

COVID-19 & Sports

COVID-19 & Sports

Untitled design (21).png

Published Work

From observational studies to clinical trials, the VIDC research team shares our findings with the medical community at international conferences.

Visit us at an upcoming conference >

Search

Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users

Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users

Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users

Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users: the GRAND PLAN study Presented at the...

Feb 28, 2020

Sofosbuvir/velpatasvir (S/V) for the treatment of chronic HCV in active drug users: the CHIME study

Sofosbuvir/velpatasvir (S/V) for the treatment of chronic HCV in active drug users: the CHIME study

Sofosbuvir/velpatasvir (S/V) for the treatment of chronic HCV in active drug users: the CHIME study

Presented at the Canadian Liver Meeting. February 28- March 1, Montreal, Canada, 2020.

Feb 28, 2020

Overdose events among active drug users successfully treated for HCV: the impact of homelessness.

Overdose events among active drug users successfully treated for HCV: the impact of homelessness.

Overdose events among active drug users successfully treated for HCV: the impact of homelessness.

Presented at the Canadian Liver Meeting. February 28- March 1, Montreal, Canada, 2020.

Feb 28, 2020

bottom of page